Hypoxia-inducible factor-1α polymorphisms associated with enhanced transactivation capacity, implying clinical significance

Carcinogenesis

Volumn 24, Issue 11, 2003, Pages 1779-1783

  Tanimoto, Keiji ^a   Yoshiga, Koji ^b   Eguchi, Hidetaka ^b,c   Kaneyasu, Mika ^a   Ukon, Kei ^a   Kumazaki, Tsutomu ^a   Oue, Naohide ^b   Yasui, Wataru ^b   Imai, Kazue ^c   Nakachi, Kei ^b,c   Poellinger, Lorenz ^d   Nishiyama, Masahiko ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; DNA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXYGEN; PROLINE; SERINE; THREONINE;

ALLELE; ANGIOGENESIS; ANIMAL CELL; ARTICLE; CANCER GROWTH; CANCER PATIENT; CELL ACTIVITY; CELL STRAIN COS7; CONTROLLED STUDY; FEMALE; GENE ACTIVITY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HEAD AND NECK CARCINOMA; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REGULATORY MECHANISM; SEQUENCE ANALYSIS; SQUAMOUS CELL CARCINOMA; TRANSACTIVATION; TUMOR GROWTH; TUMOR VOLUME; WILD TYPE;

AMINO ACID SEQUENCE; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; DNA PRIMERS; DNA-BINDING PROTEINS; EPIDEMIOLOGY, MOLECULAR; HEAD AND NECK NEOPLASMS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; POLYMORPHISM, GENETIC; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 0242559086     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgg132     Document Type: Article

References (25)

1. 2 homeostasis by hypoxia-inducible factor 1α. Genes Dev., 12, 149-162.
2. Ryan,H.E., Lo,J. and Johnson,R.S. (1998) HIF-1α is required for solid tumor formation and embryonic vascularization. EMBO J., 17, 3005-3015.
3. Folkman,J. (1999) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med., 1, 27-31.
4. Ryan,H.E., Poloni,M., McNulty,W., Elson,D., Gassmann,M., Arbeit,J.M. and Johnson,R.S. (2000) Hypoxia-inducible factor-1α is a positive factor in solid tumor growth. Cancer Res., 60, 4010-4015.
5. Semenza,G.L. (2001) HIF-1 and mechanisms of hypoxia sensing. Curr. Opin. Cell Biol., 13, 167-171.
6. Zhong,H., De Marzo,A.M., Laughner,E., Lim,M., Hilton,D.A., Zagzag,D., Buechler,P., Isaacs,W.B., Semenza,G.L. and Simons,J.W. (1999) Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res., 59, 5830-5835.
7. Bos,R., Zhong,H., Hanrahan,C.F., Mommers,E.C., Semenza,G.L., Pinedo,H.M., Abeloff,M.D., Simons,J.W., van Diest,P.J. and van der Wall,E. (2001) Levels of hypoxia-inducible factor-1α during breast carcinogenesis. J. Natl Cancer Inst., 93, 309-314.
8. Koukourakis,M.I., Giatromanolaki,A., Skarlatos,J., Corti,L., Blandamura,S., Piazza,M., Gatter,K.C. and Harris,A.L. (2001) Hypoxia inducible factor (HIF-1α and HIF-2α) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy. Cancer Res., 61, 1830-1832.
9. Kallio,P.J., Pongratz, I., Gradin,K., McGuire,J. and Poellinger,L. (1997) Activation of hypoxia-inducible factor 1α: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor. Proc. Natl Acad. Sci. USA, 94, 5667-5672.
10. Brown,J.M. and Giaccia,A.J. (1998) The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res., 58, 1408-1416.
11. Maxwell,P.H., Wiesener,M.S., Chang,G.-W., Clifford,S.C., Vaux,E.C., Cockman,M.E., Wykoff,C.C., Pugh,C.W., Maher,E.R. and Ratcliff,P. (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature, 399, 271- 275.
12. Ohh,M., Park,C.W., Ivan,M., Hoffman,M.A., Kim,T.-Y., Huang,L.E., Pavletich,N., Chau,V. and Kaelin,W.G. (2000) Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein. Nature Cell Biol., 2, 423- 427.
13. Tanimoto,K., Makino,Y., Pereira,T. and Poellinger,L. (2000) Mechanism of regulation of the hypoxia-inducible factor-1α by the von Hippel-Lindau tumor suppressor protein. EMBO J., 19, 4298-4309.
14. Masson,N., Willam,C., Maxwell,P.H., Pugh,C.W. and Ratcliffe,P.J. (2001) Independent function of two destruction domains in hypoxia-inducible factor-α chains activated by prolyl hydroxylation. EMBO J., 20, 5197-5206.
15. Bruick,R.K. and McKnight,S.L. (2001) A conserved family of prolyl-4-hydroxylases that modify HIF. Science, 294, 1337-1340.
16. Carrero,P., Okamoto,K., Coumalleau,P., O'Brien,S., Tanaka,H. and Poellinger,L. (2000) Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1α. Mol. Cell. Biol., 20, 402-415.
17. Clifford,S.C., Astuti,D., Hooper,L., Maxwell,P.H., Ratcliffe,P.J. and Maher,E.R. (2001) The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx and HIF-1α in renal cell carcinoma. Oncogene, 20, 5067-5071.
18. Tanimoto,K., Hayashi,S., Yoshiga,K. and Ichikawa,T. (1999) Polymorphisms of the CYP1A1 and GSTM1 gene involved in oral squamous cell carcinoma in association with a cigarette dose. Eur. J. Cancer Oral Oncol., 35, 191-196.
19. Kallio,P.J., Wilson,W.J., O'Brien,S., Makino,Y. and Poellinger,L. (1999) Regulation of the hypoxia-inducible transcription factor 1α by the ubiquitin-proteasome pathway. J. Biol. Chem., 274, 6519-6525.
20. Yasui,W., Ji,Z.Q., Kuniyasu,H., Ayhan,A., Yokozaki,H., Ito,H. and Tahara,E. (1992) Expression of transforming growth factor alpha in human tissues: immunohistochemical study and Northern blot analysis. Virch. Arch. A Pathol. Anat. Histopathol., 421, 513-519.
21. Semenza,G.L. (2001) Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trend Mol. Med., 7, 345-350.
22. Carmeliet,P., Dor,Y., Herbert,J.M. et al. (1998) Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature, 394, 485-490.
23. Maxwell,P.H., Dachs,G.U., Gleadle,J.M., Nicholls,L.G., Harris,A.L., Stratford,I.J., Hankinson,O., Pugh,C.W. and Ratcliffe,P.J. (1997) Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc. Natl Acad. Sci. USA, 94, 8104-8109.
24. Tsuzuki,Y., Fukumura,D., Oosthuyse,B., Koike,C., Carmeliet,P. and Jain,R.K. (2000) Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1α → hypoxia response element → VEGF cascade differentially regulates vascular response and growth rate. Cancer Res., 60, 6248-6252.
25. Burke,B., Tang,N., Corke,K.P., Tazzyman,D., Ameri,K., Wells,M. and Lewis,C.E. (2002) Expression of HIF-1α by human macrophages: implications for the use of macrophages in hypoxia-regulated cancer gene therapy. J. Pathol., 196, 204-212.